How to buy Fennec Pharmaceuticals stock (FENC)

Fennec Pharmaceuticals is a biotechnology business based in the US. Fennec Pharmaceuticals shares (FENC) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $5.99 – a decrease of 0.99% over the previous week. Fennec Pharmaceuticals employs 29 staff and has a trailing 12-month revenue of around $49.3 million.

Our top picks for where to buy Fennec Pharmaceuticals stock

Buy Fennec Pharmaceuticals stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Fennec Pharmaceuticals stock price (NASDAQ: FENC)

Use our graph to track the performance of FENC stocks over time.

Fennec Pharmaceuticals shares at a glance

• Key figures

Information last updated 2024-12-19.

Latest market close	$5.99
52-week range	$3.96 - $11.92
50-day moving average more info button	$4.99
200-day moving average more info button	$6.77
Wall St. target price	$13.60
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-0.04

Is it a good time to buy Fennec Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Fennec Pharmaceuticals price performance over time

Historical closes compared with the close of $5.84 from 2024-12-19

1 week (2024-12-13)	-3.47%
1 month (2024-11-21)	23.73%
3 months (2024-09-20)	11.45%
6 months (2024-06-21)	-9.03%

1 year (2023-12-21)	-44.49%
2 years (2022-12-21)	-42.86%
3 years (2021-12-21)	38.72%
5 years (2019-12-20)	5.91

Fennec Pharmaceuticals financials

Revenue TTM	$49.3 million
Gross profit TTM	$1.4 million
Return on assets TTM	2.7%
Return on equity TTM	-1005.59%
Profit margin	-2.3%
Book value	$-0.19
Market Capitalization more info button	$155.6 million

TTM: trailing 12 months

Fennec Pharmaceuticals share dividends

We're not expecting Fennec Pharmaceuticals to pay a dividend over the next 12 months.

Have Fennec Pharmaceuticals's shares ever split?

Fennec Pharmaceuticals's shares were split on a 1:3 basis on 4 September 2014 . So if you had owned 3 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Fennec Pharmaceuticals shares – just the quantity. However, indirectly, the new 200% higher share price could have impacted the market appetite for Fennec Pharmaceuticals shares which in turn could have impacted Fennec Pharmaceuticals's share price.

Fennec Pharmaceuticals share price volatility

Over the last 12 months, Fennec Pharmaceuticals's shares have ranged in value from as little as $3.96 up to $11.92. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Fennec Pharmaceuticals's is 0.267. This would suggest that Fennec Pharmaceuticals's shares are less volatile than average (for this exchange).

Fennec Pharmaceuticals overview

Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014.

Frequently asked questions

null
What percentage of Fennec Pharmaceuticals is owned by insiders or institutions?
Currently 16.239% of Fennec Pharmaceuticals shares are held by insiders and 54.701% by institutions. How many people work for Fennec Pharmaceuticals?
Latest data suggests 29 work at Fennec Pharmaceuticals. When does the fiscal year end for Fennec Pharmaceuticals?
Fennec Pharmaceuticals's fiscal year ends in December. Where is Fennec Pharmaceuticals based?
Fennec Pharmaceuticals's address is: 68 TW Alexander Drive, Research Triangle Park, NC, United States, 27709 What is Fennec Pharmaceuticals's ISIN number?
Fennec Pharmaceuticals's international securities identification number is: CA31447P1009 What is Fennec Pharmaceuticals's CUSIP number?
Fennec Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 00686R408